TLR3 and colitis: Lack of TLR3 and TLR7 during DSS colitis abrogated IFN-β production of colonic pDCs in response to TLR3/7 agonists indicating that type I IFN produced by pDCs may be important to counterregulate inflammation in the colon [12].